Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

188 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A graphical tool to investigate method validation.
Badrick T, Hickman P, Ward G. Badrick T, et al. Among authors: hickman p. Clin Chem Lab Med. 2023 Feb 3;61(8):e160-e162. doi: 10.1515/cclm-2023-0095. Print 2023 Jul 26. Clin Chem Lab Med. 2023. PMID: 36735545 No abstract available.
Transitioning to high-sensitivity troponin: 1-year mortality outcomes in patients with suspected acute coronary syndrome presenting to emergency departments.
Hickling S, Sanfilippo FM, Cullen L, Chew DP, Hillis GS, Fatovich DM, Karnon J, Rankin J, Nedkoff L, Scanlan S, Hickman PE, Stapleton S, Knuiman M, Parsonage W, Mitra B, Schneider HG, Wilkes G, Robinson T, Briffa T. Hickling S, et al. Among authors: hickman pe. Heart. 2025 Jan 16:heartjnl-2024-324959. doi: 10.1136/heartjnl-2024-324959. Online ahead of print. Heart. 2025. PMID: 39819623
Health Outcomes around Pregnancy and Exposure to HIV/Antiretrovirals (HOPE) study protocol: a prospective observational cohort study of reproductive-aged women living with HIV.
Kacanek D, Yee LM, Yao TJ, Lee J, Chadwick EG, Williams PL, Barr EA, Berman CA, Davtyan M, DiPerna A, Flores A, Green J, Haddad LB, Hyzy L, Jacobson DL, James-Todd T, Jao J, Khadraoui A, Malee KM, Moscicki AB, Patel K, Robinson LG, Salomon L, Sanders K, Siminski S, Smith RA, Wolbach T, Powis KM; Health Outcomes around Pregnancy and Exposure to HIV/Antiretrovirals (HOPE) Study; Health Outcomes in Pregnancy and Exposure to HIV/Antiretrovirals (HOPE) Study. Kacanek D, et al. BMJ Open. 2024 Jul 5;14(7):e084835. doi: 10.1136/bmjopen-2024-084835. BMJ Open. 2024. PMID: 38969382 Free PMC article.
Patient-Derived Tumor Xenograft Study with CDK4/6 Inhibitor Plus AKT Inhibitor for the Management of Metastatic Castration-Resistant Prostate Cancer.
Kase AM, Gleba J, Miller JL, Miller E, Petit J, Barrett MT, Zhou Y, Parent EE, Cai H, Knight JA, Orme J, Reynolds J, Durham WF, Metz TM, Meurice N, Edenfield B, Alasonyalilar Demirer A, Bilgili A, Hickman PG, Pawlush ML, Marlow L, Wickland DP, Tan W, Copland JA 3rd. Kase AM, et al. Among authors: hickman pg. Mol Cancer Ther. 2024 Jun 4;23(6):823-835. doi: 10.1158/1535-7163.MCT-23-0296. Mol Cancer Ther. 2024. PMID: 38442920
188 results